VIMTA LABS
QUARTERLY RESULTS
FOR Q/E SEP 2013
VIMTA LABS has produced improved
results for the quarter ending Sep,2013. Net Sales have gone up 11.36% QoQ and
10.48% YoY. Net Profit has gone up 2.52% QoQ and 333% YoY. EPS stands at 1.73 for Q/e
Sep 13 while it was 1.69 in preceding Quarter and 0.4 in corresponding quarter.
The Equity of the Co. is just Rs.4.4 cr.
|
VIMTA LABS
|
30-Sep-13
|
%dif QoQ
|
30-Jun-13
|
%dif YoY
|
30-Sep-12
|
|
Net Sales
|
3054.57
|
11.36
|
2742.98
|
10.48
|
2764.91
|
|
Total Expenditure
|
2554.03
|
13.37
|
2252.88
|
-2.74
|
2625.87
|
|
Profit before Interest, Dep. & Taxes
|
500.54
|
2.13
|
490.1
|
260
|
139.04
|
|
Net
Profit
|
383.49
|
2.52
|
374.07
|
332.93
|
88.58
|
|
Diluted EPS
|
1.73
|
2.37
|
1.69
|
332.5
|
0.4
|
|
Total Income
|
3054.57
|
11.36
|
2742.98
|
10.48
|
2764.91
|
|
Changes in inventories
|
24.44
|
-184.57
|
-28.9
|
-82.52
|
139.78
|
|
Cost of materials
|
610.89
|
10.05
|
555.11
|
18.91
|
513.76
|
|
Employee expense
|
671.83
|
5.78
|
635.15
|
10.46
|
608.22
|
|
Depreciation
|
250.5
|
7.27
|
233.52
|
-36.28
|
393.1
|
|
Other expenses
|
996.37
|
16.13
|
858
|
2.61
|
971.01
|
|
Total expenses
|
2554.03
|
13.37
|
2252.88
|
-2.74
|
2625.87
|
|
Profit before tax
|
514.48
|
5.11
|
489.48
|
603.71
|
73.11
|
|
Tax Expenses
|
130.99
|
13.5
|
115.41
|
-946.74
|
-15.47
|
|
Net Profit
|
383.49
|
2.52
|
374.07
|
332.93
|
88.58
|
|
Face Value of Share (in )
|
2
|
0
|
2
|
0
|
2
|
|
Paid-up Equity
|
442.16
|
0
|
442.16
|
0
|
442.16
|
|
Basic EPS
|
1.73
|
2.37
|
1.69
|
332.5
|
0.4
|
|
Public Shareholding (%)
|
62.73
|
-0.51
|
63.05
|
63.13
|
The CMP has
increased from Rs.31.60 on 25-oct-13 to
Rs.39.50 on 07-11-13 ( 3 months ago, price was around Rs.25.)
52 week
high/low price : 45.00/14.60
About the Company :
Vimta Labs is India’s leading
contract research and testing organization. Established in 1984 VIMTA has
an envious track record of serving several market leaders across the globe.
VIMTA is a team of 692 professionals
comprising 461 scientists in various disciplines such as Chemistry, Pharma,
Medicine, Microbiology, Molecular biology and Informatics. The team is
slated to double in next three years.
VIMTA is a multi-site organization with more than 300,000 sqft world class laboratory facilities.
VIMTA is a multi-site organization with more than 300,000 sqft world class laboratory facilities.
The technologies deployed at VIMTA
are current and leading edge, duly validated.
* *
* E N
D * * *
No comments:
Post a Comment